← FDA Drug Approvals (Drugs@FDA)

NITROGLYCERIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2023-12-05

Drug application

FDA Application #
ANDA217970
Application type
Abbreviated New Drug Application (Generic)
Brand name
NITROGLYCERIN
Generic name
NITROGLYCERIN
Active ingredients
NITROGLYCERIN
Dosage form
TABLET
Route
SUBLINGUAL
Marketing status
Prescription
Sponsor
MANKIND PHARMA
Manufacturer
Lifestar Pharma LLC
First approval
2023-12-05

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown